Cancer Quantx Biosciences presents new POLθ inhibitors Sep. 12, 2025 Quantx Biosciences US Inc. has synthesized DNA polymerase θ (POLQ) inhibitors reported to be useful for the treatment of cancer.Read More
Inflammatory Quantx divulges new IL-17A/A and IL-17A/F inhibitors May 5, 2025 Quantx Biosciences US Inc. has synthesized interleukin-17A/A homodimer and/or IL-17A/F heterodimer inhibitors reported to be useful for the treatment of autoimmune and inflammatory diseases.Read More
Cancer Quantx Biosciences US discovers new PARG inhibitors Dec. 18, 2024 Quantx Biosciences US Inc. has described poly(ADP-ribose) glycohydrolase (PARG) inhibitors reported to be useful for the treatment of cancer.Read More
